Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2012-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00259-012-2061-8PMID 22278320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Value of contrast‐enhanced 18F‐fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: A prospective study

  2011cited by this paper
• Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis.

  2011cited by this paper
• Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer

  2008cited by this paper
• In Vivo Characterization of Proliferation for Discriminating Cancer from Pancreatic Pseudotumors

  2008influential reference
• 18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients

  2007cited by this paper
• Endoscopic ultrasound and fine needle aspiration in chronic pancreatitis: differential diagnosis between pseudotumoral masses and pancreatic cancer.

  2007cited by this paper
• Pancreatitis Associated with Pancreatic Carcinoma

  2005cited by this paper
• Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-Effectiveness

  2005cited by this paper
• Clinical relevance of imaging proliferative activity in lung nodules

  2005cited by this paper
• In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography

  2003cited by this paper
• Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?

  2001cited by this paper
• FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies.

  1998cited by this paper
• Imaging proliferation in vivo with [F-18]FLT and positron emission tomography

  1998cited by this paper
• Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.

  1995cited by this paper

• Temporal information guided dynamic dual-tracer PET signal separation network.

  2022cites this paper
• Molecular imaging of pancreatic neoplasms

  2021cites this paper
• PET/CT in Pancreatic Neoplasms

  2021cites this paper
• Molecular radionuclide imaging of pancreatic neoplasms.

  2019cites this paper
• Development of Novel Diagnostic Pancreatic Tumor Biomarkers

  2018cites this paper
• PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.

  2018cites this paper
• PET/MR Imaging of the Pancreas.

  2018cites this paper
• Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3′-deoxy-3′-[18F] fluorothymidine in patients with lung cancer

  2017cites this paper
• A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CT

  2017cites this paper
• Development of Novel Diagnostic Pancreatic Tumor Biomarkers 2nd ed

  2017cites this paper
• Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology

  2017cites this paper
• PET-Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine Tumors.

  2017cites this paper
• Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer.

  2017cites this paper
• Imaging modalities for characterising focal pancreatic lesions.

  2017cites this paper
• Surgeons’ knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study

  2017cites this paper
• Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma: A Meta-Analysis

  2016cites this paper
• FLT PET/CT Is Better Than FDG PET/CT in Differentiating Benign From Malignant Pancreatobiliary Lesions

  2016cites this paper
• 18F-FLT PET imaging of cellular proliferation in pancreatic cancer.

  2016cites this paper
• 18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography Imaging

  2016cites this paper
• FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT

  2016cites this paper
• Investigation of 18F-Fluoro-L-Thymidine to monitor treatment response in murine models of pancreatic cancer : development of tools and validation

  2016cites this paper
• Pancreatic tumors imaging: An update.

  2016cites this paper
• Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.

  2016cites this paper
• FLT PET/CT-Guided Biopsy in the Evaluation of Cancer

  2016cites this paper
• FDG-PET/CT and FLT-PET/CT for differentiating between lipid-poor benign and malignant adrenal tumours

  2015cites this paper
• 18F-FDG activitiy PET/CT and CA-19.9 levels for the prediction of histopathological features and localization of peri- ampullary tumors.

  2015cites this paper
• F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors

  2015cites this paper
• 3′-Deoxy-3′-18F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer

  2015cites this paper
• Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma

  2014cites this paper
• Multimodal Molecular Imaging of Integrin αvβ3 for In Vivo Detection of Pancreatic Cancer

  2014cites this paper
• Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review)

  2014cites this paper
• The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer.

  2014cites this paper
• Integrated study of the effects of antiangiogenic therapy on microvascular physiology in human cancer models

  2014cites this paper
• Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis.

  2014cites this paper
• Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.

  2013cites this paper
• Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.

  2013cites this paper
• The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma

  2013cites this paper
• Usefulness of PET/CT for the Differentiation and Characterization of Periampullary Lesions

  2013influential citation
• Single-scan dual-tracer FLT+FDG PET tumor characterization

  2013cites this paper
• Combined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.

  2013cites this paper
• FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.

  2013cites this paper
• An optical proteomic profile of the HER2 family in breast tumours and the effect of exposure to tyrosine kinase inhibitors

  2013cites this paper
• The role of F-18-fluorothymidine PET in oncology

  2013cites this paper
• Combined Injection of 18F-Fluorodeoxyglucose and 3′-Deoxy-3′-[18F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study

  2013cites this paper
• Current world literature.

  2013cites this paper
• Role of SUVmax obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation

  2013cites this paper
• Methodology for Quantitative Rapid Multi-Tracer PET Tumor Characterizations

  2013cites this paper
• PET/CT in the management and prognosis of pancreatic exocrine tumors.

  2013cites this paper
• PET Imaging of Proliferation with Pyrimidines

  2013cites this paper
• How fibrosis influences imaging and surgical decisions in pancreatic cancer

  2012influential citation
• Innovation in Cancer Imaging

  2012cites this paper
• The role of stroma in pancreatic cancer: diagnostic and therapeutic implications

  2012cites this paper
• Current research in nuclear medicine and molecular imaging: highlights of the 23rd Annual EANM Congress

  2011cites this paper